Unknown Primary Squamous Cell Carcinoma
Showing 1 - 25 of >10,000
Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus
Recruiting
- Cancer of Unknown Primary Site
- +2 more
- Transoral Ultrasound
-
Copenhagen, Denmark
- +1 more
May 2, 2023
Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)
Not yet recruiting
- Head and Neck Cancer
- +2 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jan 18, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma, Unknown Primary Trial in Liverpool (Versius Surgical System)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Squamous Cell Carcinoma, Unknown Primary
- Versius Surgical System
-
Liverpool, United KingdomLiverpool Head and Neck Centre, ENT Department Liverpool Univers
Oct 27, 2023
Circulating Biomarkers in Oropharyngeal Cancers
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
-
Orebro, SwedenAnna Oldaeus Almerén
Jun 13, 2023
Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +5 more
- External Beam Radiation Therapy
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2022
Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)
Active, not recruiting
- Analgesia
- +6 more
- Dexamethasone
- Placebo
-
Copenhagen, DenmarkDepartment of Otorhinolaryngology, Head and Neck Surgery & Audio
Oct 14, 2022
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the
Recruiting
- Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
- +2 more
- Atezolizumab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 19, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell
Active, not recruiting
- Head and Neck Carcinoma of Unknown Primary
- +19 more
- Berzosertib
- +3 more
-
Duarte, California
- +18 more
Aug 24, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior
Recruiting
- Solid Tumor
- +15 more
- RAPA-201 Rapamycin Resistant T Cells
- Chemotherapy Prior to RAPA-201 Therapy
-
Hackensack, New JerseyHackensack University Medical Center
Dec 23, 2021
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +5 more
- Tolinapant
- Radiation Therapy
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 17, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Head and Neck Squamous Cell Carcinoma Trial in Toronto (da Vinci Surgical System Model IS4000)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- da Vinci Surgical System Model IS4000
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 16, 2021
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)
Not yet recruiting
- Oral Squamous Cell Carcinoma
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023
Head Neck Cancer Trial (IMRT)
Completed
- Head and Neck Cancer
- IMRT
- (no location specified)
Sep 3, 2020
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy, distant lymph node 0.5Gy*4)
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Dec 6, 2022
Esophageal Squamous Cell Carcinoma in Malawi
Completed
- Esophageal Squamous Cell Carcinoma
-
Lilongwe, Malawi
- +1 more
Jan 5, 2023
Regional Nodal Basins and Gene Expression Profiling in Primary
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Ultrasound
- 40-GEP
- (no location specified)
Jul 12, 2023